Breakfast seminar november 5th

From compound to clinic

A review of key aspects on chemical quality and manufacturing during early phases in drug development. Focus on small molecue API´s intended for use in clinical trials. Let´s discuss how to eliminate risks on the road to start clinical trials as well as some fresch EMEA guidelines regarding Potential Genotoxic Impurities (PGI´s).

Speaker: Paul Alhadeff, Syntagon
Date: November 5th 2009
Time:  08.00-09.00 AM
Location: Wenner-Gren Center, floor 24

Breakfast starting from 07.45 AM

The seminar will be held in Swedish

Download invitation here.

Download Syntagon presentation here